Investment

Building and backing category-defining companies.

Across high-science, technical subsectors of healthcare and life sciences, from formation through commercialisation and beyond.

Our model

Evidence-led and specialised.

Evidence-based investing

We are building Aleph, our own research platform, drawing on deep insights across multiple fields. We also build our own AI tools to support our portfolio and the wider ecosystem.

Highly specialised

We go deep in a few specific areas of healthcare and life sciences, building the research, networks and operating know-how to form and back companies in them.

Our strategies

A multi-stage approach.

01Live

Philanthropy and catalytic capital

Grants and catalytic capital for high-impact science, designed and delivered with donors and foundations.

Philanthropy →

02Live

Translational science

Helping promising research reach patients, with the data, partners and support to move it from lab to clinic.

ALTs Works →

03Live

Venture formation

We form new companies around unmet needs and proprietary data, and build them from first idea through to launch.

ALTs Studio →

04Coming soon

Venture capital

A specialist, focused strategy, with a thematic, conviction-led approach across a range of subsectors.

Our focus

High-science, technical subsectors.

Data and R&D Infrastructure

Analytics & Decision Intelligence

Healthtech Software & Digital

Biopharma & Services

Life Sciences Tools & Diagnostics

Medical Devices & Technologies